Surgical Science Sweden Stock Performance
| SUSRF Stock | USD 12.75 0.00 0.00% |
Surgical Science has a performance score of 1 on a scale of 0 to 100. The entity has a beta of -0.13, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Surgical Science are expected to decrease at a much lower rate. During the bear market, Surgical Science is likely to outperform the market. Surgical Science Sweden right now has a risk of 1.88%. Please validate Surgical Science risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to decide if Surgical Science will be following its existing price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surgical Science Sweden are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Surgical Science is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 87.2 M | |
| Total Cashflows From Investing Activities | -2.7 B |
Surgical |
Surgical Science Relative Risk vs. Return Landscape
If you would invest 1,253 in Surgical Science Sweden on September 1, 2024 and sell it today you would earn a total of 22.00 from holding Surgical Science Sweden or generate 1.76% return on investment over 90 days. Surgical Science Sweden is currently producing 0.0447% returns and takes up 1.8806% volatility of returns over 90 trading days. Put another way, 16% of traded pink sheets are less volatile than Surgical, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Surgical Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgical Science's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Surgical Science Sweden, and traders can use it to determine the average amount a Surgical Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0238
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SUSRF |
Estimated Market Risk
| 1.88 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Surgical Science is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgical Science by adding it to a well-diversified portfolio.
Surgical Science Fundamentals Growth
Surgical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Surgical Science, and Surgical Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgical Pink Sheet performance.
| Return On Equity | 0.0357 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.18 % | |||
| Current Valuation | 743.09 M | |||
| Shares Outstanding | 50.8 M | |||
| Price To Earning | 73.41 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 15.43 X | |||
| Revenue | 366.78 M | |||
| EBITDA | 122.27 M | |||
| Total Debt | 29.42 M | |||
| Debt To Equity | 0 % | |||
| Cash Flow From Operations | 39.08 M | |||
| Earnings Per Share | 0.28 X | |||
| Total Asset | 3.98 B | |||
About Surgical Science Performance
By analyzing Surgical Science's fundamental ratios, stakeholders can gain valuable insights into Surgical Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Surgical Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgical Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on OTC Exchange in the United States.Things to note about Surgical Science Sweden performance evaluation
Checking the ongoing alerts about Surgical Science for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Surgical Science Sweden help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 33.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Surgical Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgical Science's stock is overvalued or undervalued compared to its peers.
- Examining Surgical Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgical Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgical Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgical Science's pink sheet. These opinions can provide insight into Surgical Science's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Surgical Pink Sheet analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |